CRISPR prevents hearing loss in mice
Researchers use CRISPR-Cas9 to target a mutation in the Tmc1 gene that causes the loss of hair cells in the inner ear.
List view / Grid view
Gene Therapy is the introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders.
Researchers use CRISPR-Cas9 to target a mutation in the Tmc1 gene that causes the loss of hair cells in the inner ear.
A cure for haemophilia is one step closer, following results of a gene therapy trial led by the NHS in London.
Charles River Laboratories International, Inc. announced the expansion of its CRISPR/Cas9 service offering with the addition of a license from ERS Genomics Limited.
SMi are delighted to have, Nagy Habib, Head of HPB Surgery, Imperial College London and Co-Founder, MiNA Therapeutics, as the Keynote Address for day 1 at RNA Therapeutics 2018!
Researchers have tested whether a single injection of the gene, LeXis could slow down the development of heart disease...
A leading gene and cell therapy group has announced a collaboration focusing on gene and cell therapy manufacturing..
A research team have studied how alterations in a tumour depend on each other and how these dependencies determine cancer evolution...
A new gene therapy that targets the heart and requires only one treatment session has been found safe for patients with coronary artery disease...
Researchers have used CRISPR to stop the expression of individual genes in cancer cells, by knocking out every known protein-encoding gene in the human genome...
"Well thought through and brilliantly executed" study shows different DNA-repair mechanism in embryos compared to iPSCs
Researchers have found a pattern of genes which is characteristic of osteoarthritis and may be a step towards better treatments for this condition.
A new study conducted by an international team of lung cancer researchers have identified new genetic variants for lung cancer risk.
This latest funding round attracts two prominent new investors; Brian Kennedy and Sir Brian Souter.
MRC-funded researchers have identified properties in DNA’s protective structure that could transform the way scientists think about the human genome.
New research led by Queen’s University Belfast has discovered how a genomic approach to understanding bowel cancer could improve the prognosis and quality of life for patients.